Tumour sizes along the course of the in vivo growth were then recorded, revealing that RDM1 knockdown markedly decreased tumour size (Figure 5A), weight (Figure 5B) and volume (Figure 5C) relative to the control group, confirming the oncogenic role of RDM1 in breast cancer progression. This evidence concerns the gene RDM1 and neoplasm.